APYX Logo

Apyx Medical Corporation (APYX) Insider Trading Activity

NASDAQ$1.43
Market Cap
$54.05M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
380 of 877
Rank in Industry
46 of 109

APYX Insider Trading Activity

APYX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$6,780
1
100
Sells
$0
0
0

Related Transactions

HILL MATTHEW CChief Financial Officer
1
$6,780
0
$0
$6,780

About Apyx Medical Corporation

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Insider Activity of Apyx Medical Corporation

Over the last 12 months, insiders at Apyx Medical Corporation have bought $6,780 and sold $0 worth of Apyx Medical Corporation stock.

On average, over the past 5 years, insiders at Apyx Medical Corporation have bought $49,654 and sold $113,400 worth of stock each year.

Highest buying activity among insiders over the last 12 months: HILL MATTHEW C (Chief Financial Officer) — $6,780.

The last purchase of 6,000 shares for transaction amount of $6,780 was made by HILL MATTHEW C (Chief Financial Officer) on 2024‑08‑13.

List of Insider Buy and Sell Transactions, Apyx Medical Corporation

2024-08-13PurchaseHILL MATTHEW CChief Financial Officer
6,000
0.0183%
$1.13
$6,780
+17.73%
2023-12-12PurchaseHILL MATTHEW CChief Financial Officer
2,500
0.0071%
$2.19
$5,475
-35.32%
2023-11-14PurchaseGoodwin Charles D. IIChief Executive Officer
50,000
0.1498%
$1.57
$78,500
-5.00%
2023-06-26SaleHornsby ToddExecutive Vice President
15,000
0.0434%
$7.56
$113,400
-69.21%
2022-08-29PurchaseGoodwin Charles D. IIChief Executive Officer
9,750
0.0286%
$5.97
$58,208
-30.27%
2020-05-13PurchaseGoodwin Charles D. IIChief Executive Officer
28,250
0.0829%
$3.30
$93,197
+101.67%
2016-08-17PurchaseMcCarthy John J. IIIChief CommercializationOfficer
181,500
0.2685%
$3.30
$598,950
2015-12-22PurchaseMcCarthy John J. IIIChief Commercialization Office
50,000
0.0443%
$1.98
$98,855
2015-12-21PurchaseCITRONOWICZ MOSHESr. V.P. of Operations
40,000
0.033%
$1.84
$73,548
2015-12-21PurchaseGershon RobertChief Executive Officer
20,000
0.0163%
$1.82
$36,336
2015-08-14PurchaseGershon RobertChief Executive Officer
40,000
0.0429%
$2.39
$95,600
2011-12-23SaleKonesky Gregory Alandirector
1,500
0.0016%
$2.40
$3,600
2011-08-25PurchaseRENN Universal Growth Investment Trustdirector
14,200
0.0172%
$2.70
$38,340
2011-08-24PurchaseRENN Universal Growth Investment Trustdirector
28,200
0.0337%
$2.66
$75,063
2011-08-23PurchaseRENN Universal Growth Investment Trustdirector
23,200
0.0265%
$2.55
$59,160
2011-08-09PurchaseRENN Universal Growth Investment Trust10 percent owner
230,000
0.2478%
$2.40
$552,700
2011-06-08SaleKROMER GEORGE Wdirector
10,000
0.0129%
$2.87
$28,700
2011-05-20SaleKonesky Gregory Alandirector
1,600
0.0021%
$2.99
$4,784
2011-03-07PurchaseRENN Universal Growth Investment Trust10 percent owner
300,000
0.3456%
$2.57
$771,000
2010-12-03SalePardoll Peterdirector
12,156
0.0168%
$3.08
$37,440
Total: 70
*Gray background shows transactions not older than one year

Insider Historical Profitability

20.45%
HILL MATTHEW CChief Financial Officer
8500
0.0225%
$12,155.0020
<0.0001%
RENN Universal Growth Investment Trustdirector
1247800
3.3016%
$1.78M50
MAKRIDES ANDREWCEO
599213
1.5855%
$856,874.5906
CITRONOWICZ MOSHESr. V.P. of Operations
426504
1.1285%
$609,900.72112
SARON J ROBERTChief Sales & Mkt Officer
387319
1.0248%
$553,866.17014
KROMER GEORGE Wdirector
261508
0.6919%
$373,956.4403
McCarthy John J. IIIChief CommercializationOfficer
115750
0.3063%
$165,522.5020
Goodwin Charles D. IIChief Executive Officer
90000
0.2381%
$128,700.0030
+48.34%
Pardoll Peterdirector
60651
0.1605%
$86,730.9303
Gershon RobertChief Executive Officer
30000
0.0794%
$42,900.0020
GRECO ALFRED Vdirector
16500
0.0437%
$23,595.0012
Rossi Randy Ddirector
10000
0.0265%
$14,300.0003
MADDEN BRIANdirector
7500
0.0198%
$10,725.0030
Konesky Gregory Alandirector
1750
0.0046%
$2,502.5004
ACMI CORP10 percent owner
0
0%
$010
PEABODY CHARLES
0
0%
$002
Hornsby ToddExecutive Vice President
0
0%
$001
*Gray background shows insiders who have made transactions during last year

APYX Institutional Investors: Active Positions

Increased Positions19+37.25%4M+29.78%
Decreased Positions19-37.25%690,782-5.43%
New Positions6New3MNew
Sold Out Positions3Sold Out174,292Sold Out
Total Postitions510%16M+24.35%

APYX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Nantahala Capital Management, Llc$3,962.008.34%3.17M+3MNew2024-12-31
Archon Capital Management Llc$3,925.008.26%3.14M+25,000+0.8%2024-12-31
Royce & Associates Lp$3,269.006.88%2.62M+32,879+1.27%2024-12-31
Vanguard Group Inc$1,845.003.88%1.48M-5,112-0.34%2024-12-31
Silverberg Bernstein Capital Management Llc$808.001.7%646,569+75,337+13.19%2025-03-31
Horizon Kinetics Asset Management Llc$769.001.62%615,00000%2024-12-31
Commonwealth Equity Services, Llc$659.001.39%527,061+15,500+3.03%2024-12-31
Taylor Frigon Capital Management Llc$642.001.35%513,665-32,083-5.88%2025-03-31
Blackrock, Inc.$619.001.3%495,112-1,365-0.28%2025-03-31
Geode Capital Management, Llc$441.000.93%352,809+24,596+7.49%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.